HEALTH TECHNOLOGY

Sonde Health Inks MultiYear Partnership with Koye Pharmaceuticals

Sonde Health | August 25, 2022 | Read time : 03:00 min

Sonde Health

Sonde Health, a leading enterprise vocal biomarker company, has signed a multi-year agreement with Koye Pharmaceuticals, a specialty pharma organization focused on the Indian Pharmaceutical market, to develop a new vocal biomarker detection and monitoring capability for chronic obstructive pulmonary disease in India. This deal represents Sonde’s first partnership with a pharmaceutical company.

As part of this arrangement, Koye will leverage Sonde’s vocal biomarker development (VBD) platform, expanding upon its already existing respiratory responsive vocal biomarker, to create an entirely novel vocal biomarker for COPD in India. This will allow Koye to develop solutions that help track and treat respiratory health in COPD patients using their voice.

This collaboration marks a major milestone in Sonde Health’s growth and evolution, and we’re excited to take this step with Koye Pharmaceuticals. Partnering directly with pharmaceutical companies allows them to take a more targeted and engaging approach with prospective patients, aligning their needs with the most impactful therapeutics. While there’s no cure for COPD, this new vocal biomarker will allow physicians to better manage their patients’ symptoms using early monitoring and constant engagement to ensure those impacted by COPD get on the right treatment plans early and often.”

David Liu, CEO of Sonde Health

COPD, a chronic inflammatory lung disease that creates airflow blockage and makes it difficult to breathe, is the third leading cause of death worldwide – causing 3.23 million deaths in 2019, according to the World Health Organization – and the second highest cause of death and disability in adjusted life years (DALYs) in India after heart disease, per the University of Washington’s Global Burden of Disease study. As of 2018, India had 18% of the world’s population, but 32% of the COPD cases. COPD was responsible for 13% of all deaths in India. A worldwide study has estimated that India’s death rate from COPD during 2019 was 98 per 100,000 population, three times the American rate of 33 and the British rate of 31. According to the latest figures, India has an estimated 50 million people living with COPD.

“We have been keen on utilizing an accessible platform with digital biomarkers that will both aid physicians in identifying and understanding their patients’ conditions better and also make it easier for patients with chronic respiratory conditions to monitor their health in the least invasive way possible. This partnership with Sonde Health is exactly what we were looking for,” said Preetish Toraskar, Founder and Director at Koye Pharmaceuticals. “Not only is Sonde at the forefront of vocal biomarker technology, but their extensive experience in respiratory health will prove invaluable as we work to get this debilitating condition under control in India.”

Sonde Health has previously developed and commercialized vocal biomarker technology to detect and monitor respiratory impairment. In early 2022, the company partnered with GN Group, a leading global manufacturer of hearing instruments and audiological diagnostics equipment and headsets, to create vocal biomarker technology to detect Mild Cognitive Impairment.

About Sonde Health
Sonde Health has developed an enterprise vocal biomarker platform that enables any company to either license respiratory or mental fitness monitoring product or create a novel vocal biomarker product. Sonde scales data collection, feature development, model creation and clinical validation in collaboration with its partners and customers. Leveraging over 1 million voice samples from 80,000+ individuals, Sonde uses advanced audio signal processing and machine learning to sense and analyze subtle vocal changes due to changes in a person’s physiology to provide key insights into health and well-being.

About Koye Pharmaceuticals
Koye Pharmaceuticals Pvt. Ltd. was founded in 2013 by two experienced professionals of the pharma industry, Mr. Preetish Toraskar and Mr. Ravindra Shenoy. Since its foundation, Koye has expanded its operations to run across the length and breadth of the country aided by their strong distribution network. Koye today has more than 1250+ qualified ambassadors who meet up with more than 100,000+ doctors across the country every month. The company which believes in pursuing 'healthiness' has a strong foothold in different therapeutic segments that include state-of-the-art products in Specialty Primary Care, Respiratory, Gynaecology, IVF and Cardio-Diabetic segments.

Spotlight

Bronchial Thermoplasty, a clinically proven therapy with long-term results that transforms the lives of adults with severe uncontrolled asthma for at least 5 years, may be an alternative treatment option.

Spotlight

Bronchial Thermoplasty, a clinically proven therapy with long-term results that transforms the lives of adults with severe uncontrolled asthma for at least 5 years, may be an alternative treatment option.

Related News

HEALTHTECH SECURITY,FUTURE OF HEALTHCARE

Sightpath Medical Acquires Accusite Surgical

Sightpath Medical | November 22, 2022

Sightpath Medical, the leading provider of mobile ophthalmic services for cataract and refractive surgery, announced that it has acquired Accusite Surgical, a cataract surgery equipment outsourcing company. Founded in 1991, Sightpath Medical delivers custom access to advanced ophthalmic equipment, instruments, and services to facilities and surgeons across the United States. Through its patented technology, the company was the first to mobilize phacoemulsification machines, excimer lasers, the IntraLase Femtosecond Laser, and the LenSx Femtosecond Laser. Sightpath Medical has earned the trust of medical professionals and patients nationwide through the quality of its equipment, the skill of its employees, and the dedication and responsiveness of its staff. Accusite Surgical is a mobile cataract surgical company that outsources state-of-the-art equipment, technology, and certified staff to surgeons, ambulatory surgical centers, and hospitals. For over 28 years, the company has assisted in more than 200,000 procedures throughout the Southeastern U.S. In connection with the transaction, D. Lynn Godfrey, Founder and Chief Executive Officer of Accusite Surgical, will join Sightpath Medical as Chief Strategy Officer. “This strategic combination bolsters Sightpath Medical’s market-leading position and enhances our ability to deliver variable, tailored access to the expert personnel, equipment, and supplies surgeons need to provide critical eye care. We are delighted to begin integrating the Accusite Surgical business into ours and are equally excited to welcome Lynn Godfrey, who is an experienced and creative executive, to our management team. We look forward to growing Sightpath Medical together.” Joel Gaslin, President and CEO of Sightpath Medical Mr. Godfrey added, “After 28 years, I began exploring the long-term options for my business and quickly determined that the Sightpath Medical executive team and its financial partner, MGG Investment Group, were the right partners for Accusite Surgical. We are closely aligned on our core mission of helping surgeons and their referring Optometrists provide patients with excellent eye care and, ultimately, better vision. I am thrilled to commence Accusite Surgical’s next chapter as part of Sightpath Medical.” About Sightpath Medical Sightpath Medical is the leading U.S. provider of mobile ophthalmic services for cataract, refractive and laser-assisted surgery. Working alongside more than 1,200 surgeons and the staffs of their surgical facilities for more than 30 years, Sightpath Medical is the market-leading choice for surgeons, ASCs, and hospitals due to our proven ability to deliver the staff, equipment, and supplies wherever and whenever they are needed – regardless of geography. About Accusite Surgical For nearly three decades, Accusite Surgical has been a leading provider of state-of-the-art equipment, supplies, and support for cataract surgery in the Southeastern United States. Accusite Surgical is a trusted partner to ASCs and hospitals and ophthalmologists for cataract surgery services and is committed to helping surgeons grow their practices while delivering superior outcomes for patients.

Read More

HEALTH TECHNOLOGY

Netsmart Announces Intent to Become a Qualified Health Information Network to Drive the Evolution of Interoperability

Netsmart | September 23, 2022

Netsmart, the developer of the industry-leading CareFabric® platform for human services, post-acute care providers and payers announced its intent to apply to join the Trusted Exchange Framework and Common Agreement to become a Qualified Health Information Network. By supporting TEFCA, Netsmart continues its decade-long advancement of interoperability strategies to facilitate an open exchange of longitudinal healthcare data that will benefit individuals receiving care across the healthcare ecosystem. Once accepted as a QHIN, Netsmart will be part of a first-of-a-kind national data sharing network that will determine new standards for both private and public sectors. The Office of the National Coordinator for Health Information Technology is leading the charge and will oversee the QHIN process through the designation of The Sequoia Project as the recognized coordinating entity. Netsmart has been collaborating with the ONC and The Sequoia Project to help develop and provide feedback on the principles and procedures put forth by TEFCA. Netsmart is a longtime leader and advocate for open networks and interoperability standards to prioritize the needs of providers, clinicians, patients, and their families. This open network approach is in contrast to technology vendors who in some cases have sought to carve out proprietary networks that stifle the future of care coordination. The open and secure sharing of data is required to achieve effective care coordination that Netsmart supports as a founding member of the Carequality interoperability framework. The Netsmart network, CareConnect™, was built to offer clients seamless integration of health data and one point of access to the larger health data ecosystem. With the CareConnect solution, Netsmart was one of the first healthcare IT vendors to utilize the new 360X closed-loop referral standards in a production environment to bring to life true interoperability to minimize manual data entry which streamlines transitions of care and care coordination and reduces medication errors. By empowering providers to digitize their enterprise, Netsmart clients are projected to perform more than 3 billion secure health data exchanges facilitated through CareConnect in 2022. “It has always been our objective as a healthcare technology partner to offer comprehensive solutions and services that allow providers to remain competitive in a landscape that requires coordinated care and value-based practices for success. Becoming a Qualified Health Information Network aligns with our established history of being at the forefront of driving interoperability. As we take the next step in the evolution of data exchange, we look forward to collaborating with other healthcare IT vendors applying to participate as a QHIN to expand access to open networks for consumers nationwide.” Netsmart CEO Mike Valentine About Netsmart Netsmart, a leading provider of Software as a Service technology and services solutions, designs, builds and delivers electronic health records, health information exchanges, analytics and telehealth solutions and services that are powerful, intuitive and easy-to-use. Our platform provides accurate, up-to-date information that is easily accessible to care team members in the human services and post-acute care (which is comprised of home care and hospice and senior living) and payer markets. We make the complex simple and personalized so our clients can concentrate on what they do best: provide services and treatment that support whole-person care. By leveraging the powerful Netsmart network, care providers can seamlessly and securely integrate information across communities, collaborate on the most effective treatments and improve outcomes for those in their care. Our streamlined systems and personalized workflows put relevant information at the fingertips of users when and where they need it.

Read More

FUTURE OF HEALTHCARE

Lionel Richie Partners With All-In-One Healthcare Company, Devoted Health

Devoted Health | October 04, 2022

The iconic singer, actor, and American Idol judge, Lionel Richie is partnering with Devoted Health, a new kind of healthcare company providing all-in-one care for Americans on Medicare. Richie has long been dedicated to improving healthcare access, and through this partnership, he will support Devoted Health’s expanding efforts to offer higher-quality care to more Americans on Medicare across the country. “Getting great healthcare needs to be a lot easier for folks. Devoted is making this happen by bringing all of the ingredients for quality healthcare together.” Richie said. “Devoted cares for each member with all-in-one healthcare. Better quality healthcare from better coordination of care can really make a difference to folks who want to live their best and most fulfilling lives. I am excited to partner with Devoted to change and improve healthcare in America!” Devoted Health is changing healthcare for the better through its innovative all-in-one healthcare solution, which combines Devoted Health Medicare Advantage plans, access to top local providers alongside specialized care delivered by Devoted Medical, full-service guides for more personalized coordination, and world-class technology that powers it all. The result of bringing these exceptional ingredients together into one seamless offering is a complete, coordinated, and customized healthcare experience for each Devoted member. "We are thrilled to work with Lionel Richie, who is such an inspiring leader and so deeply passionate about making healthcare easier for everyone. We couldn't imagine a better spokesperson and ally than Lionel Richie." Todd Park, Executive Chairman of Devoted Health About Devoted Health Devoted Health is an all-in-one healthcare company on a mission to dramatically improve the health and well-being of older Americans by caring for every person like family. To accomplish this, Devoted Health has designed and built an integrated healthcare solution that combines Devoted Health Medicare Advantage plans, access to top local providers alongside virtual and in-home care delivered by Devoted Medical, full-service guides, and world-class technology that powers it all. The result of bringing all of these exceptional ingredients into one seamless offering is a complete, coordinated, and customized healthcare experience for each Devoted member. Founded in 2017 by brothers Todd and Ed Park, Devoted now serves over 70,000 members across Florida, Texas, Arizona, Ohio, and Illinois.

Read More